
Bioorganic and Medicinal Chemistry Letters p. 1867 - 1872 (1998)
Update date:2022-09-26
Topics:
Hulme, Christopher
Moriarty, Kevin
Miller, Bruce
Mathew, Rose
Ramanjulu, Mercy
Cox, Paul
Souness, John
Page, Ken M.
Uhl, Joanne
Travis, Jeffrey
Huang, Fu-Chih
Labaudiniere, Richard
Djuric, Stevan W.
This communication describes the synthesis and in vitro evaluation of a novel potent series of phosphodiesterase type (IV) (PDE4) inhibitors. The compounds described contain an indole moiety which replaces the 'rolipram- like' 3-methoxy-4-cyclopentoxy motif. Several of the compounds presented possess low nanomolar IC50's for PDEIV inhibition. In vivo activities determined from measurement of serum TNF-α levels in LPS challenged mice (mouse endotoxemia model) are also reported.
View MoreNanjing lanbai chemical Co.,Ltd.
Contact:+86-25-85499326
Address:Room 908, 9F Taiyue Building,No.285 Heyan Road
Changzhou Screw International Trading Co., Ltd.
Contact:13906149256,18001495888
Address:Jiangsu,Jintanqu
Contact:0086 533 2282832
Address:Zibo,Shandong
SHANDONG CREDAGRI CHEMICAL CO., LTD.
Contact:+86-531-88872050
Address:ROOM 601A, BUILDING 2, SHUNTAI SQUARE, NO. 2000 SHUNHUA ROAD, HI-TECH DEVELOPMENT ZONE, JINAN, CHINA.
Tianjin Boron PharmaTech Co.,Ltd.(expird)
Contact:86-022-59845187
Address:B9-401, Tianda Science Park,No.80,4th Avenue,TEDA,Tianjin, China
Doi:10.1016/0584-8539(96)01680-7
(1996)Doi:10.1002/ardp.19973301205
(1997)Doi:10.3390/ijms20215481
(2019)Doi:10.1007/BF02253171
(1997)Doi:10.1039/DT9920002651
(1992)Doi:10.1055/s-1995-3887
(1995)